INTERLEUKIN GENETICS INC Proceeds from Issuance Initial Public Offering
INTERLEUKIN GENETICS INC reported Proceeds from Issuance Initial Public Offering of -$988.63 thousand for the 9-month period ending 2013-09-30, per its 10-Q filed 2013-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2013-11-14
- INTERLEUKIN GENETICS INC proceeds from issuance initial public offering for the quarter ending 2013-09-30 was -$129.42K.
- INTERLEUKIN GENETICS INC proceeds from issuance initial public offering for the quarter ending 2012-09-30 was -$281.12K.
| Period end | Proceeds from Issuance Initial Public Offering 3 month | Proceeds from Issuance Initial Public Offering 6 month | Proceeds from Issuance Initial Public Offering 9 month |
|---|---|---|---|
| 2013-09-30 | -$129.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$988.63K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | -$859.21K 10-Q · filed 2013-08-14 | ||
| 2012-09-30 | -$281.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$281.12K 10-Q · filed 2013-11-14 | |
| 2012-06-30 | $0.00 10-Q · filed 2013-08-14 |